Jean De Gunzburg
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A modelling framework to characterize the impact of antibiotics on the gut microbiota diversity.
Journal: Gut microbes
Published: December 23, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.
Journal: Nature communications
Published: June 05, 2024
A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors.
Journal: Frontiers in oncology
Published: October 20, 2022
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.
Journal: The Journal of antimicrobial chemotherapy
Published: July 05, 2021
Spare and repair the gut microbiota from antibiotic-induced dysbiosis: state-of-the-art.
Journal: Drug discovery today
Published: November 02, 2020
A Colon-Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects.
Journal: Clinical pharmacology in drug development
Published: September 30, 2020
Armand Tavitian (1931-2020): from oncogenes to the Ras superfamily
Journal: Medecine sciences : M/S
Published: August 22, 2020
Optimization of an Assay To Determine Colonization Resistance to Clostridioides difficile in Fecal Samples from Healthy Subjects and Those Treated with Antibiotics.
Journal: Antimicrobial agents and chemotherapy
Published: July 07, 2020
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics.
Journal: Nature communications
Published: June 11, 2020
Microbiota-based markers predictive of development of Clostridioides difficile infection.
Journal: Nature communications
Published: June 11, 2020
Pierre Chardin, a pioneer in the discovery of the genes and proteins of the Ras superfamily
Journal: Medecine sciences : M/S
Published: May 02, 2020
Modeling the Effect of DAV132, a Novel Colon-Targeted Adsorbent, on Fecal Concentrations of Moxifloxacin and Gut Microbiota Diversity in Healthy Volunteers.
Journal: Clinical pharmacology and therapeutics
Published: February 05, 2020
Last Updated: 09/26/2026